Your browser doesn't support javascript.
loading
Characteristics and Trends in Clinical Trials of Cardiovascular Drugs in China from 2009 to 2021.
Hao, Jun; Li, Chen; Li, Junrong; Wang, Chuangshi; Li, Yang; He, Chen; Liu, Weida; Li, Sidong; Zuo, Ling; Hui, Wen.
Affiliation
  • Hao J; Medical Research and Biometrics Center, National Clinical Research Center for Cardiovascular Diseases, Fuwai Hospital, National Center for Cardiovascular Diseases, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China.
  • Li C; Department of Cardiology, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China.
  • Li J; Fujian Provincial Center for Disease Control and Prevention, Fuzhou, China.
  • Wang C; Medical Research and Biometrics Center, National Clinical Research Center for Cardiovascular Diseases, Fuwai Hospital, National Center for Cardiovascular Diseases, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China.
  • Li Y; Medical Research and Biometrics Center, National Clinical Research Center for Cardiovascular Diseases, Fuwai Hospital, National Center for Cardiovascular Diseases, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China.
  • He C; Department of Cardiology, The Guangxi Zhuang Autonomous Region Workers' Hospital, Nanning, Guangxi, China.
  • Liu W; Medical Research Center, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China.
  • Li S; Medical Research and Biometrics Center, National Clinical Research Center for Cardiovascular Diseases, Fuwai Hospital, National Center for Cardiovascular Diseases, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China.
  • Zuo L; Department of Integrated Care Management Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
  • Hui W; Department of Science and Technology, West China Hospital, Sichuan University, Chengdu, Sichuan, China. huiwen@wchscu.cn.
Am J Cardiovasc Drugs ; 23(3): 301-310, 2023 May.
Article in En | MEDLINE | ID: mdl-36917444
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cardiovascular Agents / Cardiovascular Diseases / Hypertension Type of study: Prognostic_studies Limits: Humans Country/Region as subject: Asia Language: En Journal: Am J Cardiovasc Drugs Journal subject: ANGIOLOGIA / CARDIOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2023 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cardiovascular Agents / Cardiovascular Diseases / Hypertension Type of study: Prognostic_studies Limits: Humans Country/Region as subject: Asia Language: En Journal: Am J Cardiovasc Drugs Journal subject: ANGIOLOGIA / CARDIOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2023 Document type: Article Affiliation country: Country of publication: